Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 205

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 205
---
 purchase price of $ 33.64. From March 13, 2023 to June 30, 2023, the Company issued 4,948shares of common stock in connection with notices of alternative cashless exercise for the Class C Common Stock Warrants issued in connection with the February 2023 Public Offering. On April 18, 2023, the Company issued 8shares of common stock in connection with vested Rollover RSU awards. Common Stock Issuance during the year ended December 31, 2024 On January 29, 2024, the Company issued 212shares of common stock in connection with notices of alternative cashless exercise for the Class C Common Stock Warrants issued in connection with the February 2023 Public Offering. On February 5, 2024, the Company issued 8,029shares of its common stock in connection with the February 2024 Public Offering. The Company received net cash proceeds of $ 5.4million. Between February 5, 2024 and February 13, 2024, the Company issued 77,282shares of common stock in connection with notices of cash exercise for Class D Pre-Funded Warrants issued in connection with the February 2024 Public Offering with a total purchase price of $ 123.65. On June 11, 2024, as part of the Class D Warrant Inducement the Company issued 653shares of its common stock to a third party consultant for services provided totaling $ 25,000. On August 22, 2024, the Company issued 6,312shares of common stock in connection with a notice of cash exercise for the Class D Common Stock Warrants issued in connection with the February 2024 Public Offering with a total purchase price of $ 241,390. F-17 REVELATION BIOSCIENCES, INC.
Notes to the Consolidated Financial Statements 8. Common Stock(cont.)

Between August 22, 2024
and September 20, 2024, the Company issued shares of common stock in connection with notices of cash exercise for the
Class D Common Stock Existing Warrants issued in connection with the Class D Warrant Inducement with a total purchase price
of $ million.

Between December 3, 2024
and December 6, 2024, the Company issued shares of common stock in connection with notices of cash exercise for the
Class E Common Stock Existing Warrants issued in connection with the Class